Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Valerian E Kagan,Gaowei Mao,Feng Qu,Jose Pedro Friedmann Angeli,Sebastian Doll,Claudette St Croix,Haider Hussain Dar,Bing Liu,Vladimir A Tyurin,Vladimir B Ritov,Alexandr A Kapralov,Andrew A Amoscato,Jianfei Jiang,Tamil Anthonymuthu,Dariush Mohammadyani,Qin Yang,Bettina Proneth,Judith Klein-Seetharaman,Simon Watkins,Ivet Bahar,Joel Greenberger,Rama K Mallampalli,Brent R Stockwell,Yulia Y Tyurina,Marcus Conrad,Hülya Bayır
DOI: https://doi.org/10.1038/nchembio.2238
Abstract:Enigmatic lipid peroxidation products have been claimed as the proximate executioners of ferroptosis-a specialized death program triggered by insufficiency of glutathione peroxidase 4 (GPX4). Using quantitative redox lipidomics, reverse genetics, bioinformatics and systems biology, we discovered that ferroptosis involves a highly organized oxygenation center, wherein oxidation in endoplasmic-reticulum-associated compartments occurs on only one class of phospholipids (phosphatidylethanolamines (PEs)) and is specific toward two fatty acyls-arachidonoyl (AA) and adrenoyl (AdA). Suppression of AA or AdA esterification into PE by genetic or pharmacological inhibition of acyl-CoA synthase 4 (ACSL4) acts as a specific antiferroptotic rescue pathway. Lipoxygenase (LOX) generates doubly and triply-oxygenated (15-hydroperoxy)-diacylated PE species, which act as death signals, and tocopherols and tocotrienols (vitamin E) suppress LOX and protect against ferroptosis, suggesting a homeostatic physiological role for vitamin E. This oxidative PE death pathway may also represent a target for drug discovery.